FindMyKOL
Clinical trialNCT01173874CompletedPhase 3Interventional

Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone

SponsorNew York State Psychiatric InstituteEnrollment120Schizophrenia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The investigators hypothesize that cognitive remediation will be superior to the active control group on the change from baseline to study end point of cognitive remediation phase on both co-primary outcome measures (standardized composite MATRICS score and Cognitive Assessment Interview).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • San Fernando Mental Health Center

    Granada Hills, California, United States

  • University of California - Irvine

    Orange, California, United States

  • Yale University

    New Haven, Connecticut, United States

  • University of Miami Department of Psychiatry

    Miami, Florida, United States

  • Medical College of Georgia

    Augusta, Georgia, United States

  • Northwestern University

    Chicago, Illinois, United States

  • Rush University Psychiatric Clinical Research Center

    Chicago, Illinois, United States

  • Indiana University

    Indianapolis, Indiana, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • University of Missouri

    Columbia, Missouri, United States

  • Columbia University

    New York, New York, United States

  • Psychopharmacology Research Unit- Nathan Kiine Institute for Psychiatric Research

    New York, New York, United States

  • Duke University Medical Center

    Butner, North Carolina, United States

  • University of Texas Southwestern Medical Center at Dallas

    Dallas, Texas, United States

  • University of Texas Health Science Center, San Antonio

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cognitive Remediation
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2010
Primary completion
31 Oct 2013
Completion
30 Nov 2013
Last update posted
11 Apr 2017
Registered enrollment
120
Registry id
NCT01173874
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.